Clinical trial
The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
NCT00473408 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
- Lead sponsor
- Haukeland University Hospital
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 31, 2007
- Completion date
- November 30, 2011
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anaplastic astrocytoma, glioblastoma multiforme, tumor angiogenesis